COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR
1 Assignment
0 Petitions
Accused Products
Abstract
Compounds active on protein kinases are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.
59 Citations
20 Claims
-
1. A compound of formula (Ic):
- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 16, 18)
-
2. The compound of claim 1, wherein R2 is hydrogen.
-
3. The compound of claim 2, wherein R2 is halogen.
-
4. The compound of claim 2, wherein R3 is optionally substituted phenyl.
-
5. The compound of claim 2, wherein R3 is phenyl optionally substituted with one or more halogen substituents.
-
6. The compound of claim 1, wherein R3 is phenyl optionally substituted with one or more fluoro substituents.
-
7. The compound of claim 6, wherein R3 is phenyl substituted with two fluoro substituents.
-
8. The compound of claim 1, wherein each R1 is independently optionally substituted lower alkyl or optionally substituted heteroaryl.
-
9. The compound of claim 8, wherein one R1 is lower alkyl and the other R1 is heteroaryl substituted with one or more NH2 groups.
-
10. The compound of claim 8, wherein one R1 is lower alkyl and the other R1 is pyrimidinyl substituted with one or more NH2 groups.
-
11. The compound of claim 10, wherein one R1 is t-butyl and the other R1 is pyrimidinyl substituted with NH2.
-
12. The compound of claim 1, wherein Ar is:
-
13. The compound of claim 12, wherein Ar is thiazolyl.
-
14. The compound of claim 12, wherein Ar is 4-thiazolyl.
-
16. A pharmaceutical composition comprising:
- a compound of claim 1 and a pharmaceutically acceptable carrier or excipient.
-
18. A pharmaceutical composition comprising a compound of claim 1 and another therapeutic agent.
-
2. The compound of claim 1, wherein R2 is hydrogen.
-
15. A compound of formula (Ic):
- View Dependent Claims (17, 19, 20)
-
17. A pharmaceutical composition comprising:
- a compound of claim 15 and a pharmaceutically acceptable carrier or excipient.
-
19. A method for treating a subject suffering from melanoma, thyroid cancer or colorectal cancer, said method comprising:
- administering to the subject an effective amount of a compound of claim 15.
-
20. The method of claim 19, wherein the melanoma is melanoma having a mutation encoding a V600E amino acid substitution.
-
17. A pharmaceutical composition comprising:
Specification
- Resources
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
-
Current AssigneePlexxikon Inc (Daiichi Sankyo Company Limited)
-
Original AssigneePlexxikon Inc (Daiichi Sankyo Company Limited)
-
InventorsWu, Guoxian, Zhang, Jiazhong, Zhu, Yong-Liang, Zhang, Chao, Ibrahim, Prabha N., Shi, Songyuan, Spevak, Wayne, Artis, Dean R., Tsai, James
-
Application NumberUS13/926,959Publication NumberTime in Patent OfficeDaysField of SearchUS Class Current514/222.5CPC Class CodesA61K 2300/00 Mixtures or combinations of...A61K 31/415 1,2-DiazolesA61K 31/42 OxazolesA61K 31/433 ThidiazolesA61K 31/437 the heterocyclic ring syste...A61K 31/44 Non condensed pyridines; Hy...A61K 31/4427 containing further heterocy...A61K 31/4436 containing a heterocyclic r...A61K 31/4439 containing a five-membered ...A61K 31/444 containing a six-membered r...A61K 31/4545 containing a six-membered r...A61K 31/47 Quinolines; IsoquinolinesA61K 31/505 Pyrimidines; Hydrogenated p...A61K 31/506 not condensed and containin...A61K 31/5377 not condensed and containin...A61K 31/549 having two or more nitrogen...A61K 45/06 Mixtures of active ingredie...A61P 1/04 for ulcers, gastritis or re...A61P 1/16 for liver or gallbladder di...A61P 1/18 for pancreatic disorders, e...A61P 11/00 : Drugs for disorders of the ...A61P 11/02 : Nasal agents, e.g. deconges...A61P 11/06 : AntiasthmaticsA61P 13/08 : of the prostateA61P 13/12 : of the kidneysA61P 15/00 : Drugs for genital or sexual...A61P 15/10 : for impotenceA61P 17/00 : Drugs for dermatological di...A61P 17/02 : for treating wounds, ulcers...A61P 17/04 : AntipruriticsA61P 17/06 : AntipsoriaticsA61P 17/14 : for baldness or alopeciaA61P 19/00 : Drugs for skeletal disordersA61P 19/02 : for joint disorders, e.g. a...A61P 19/08 : for bone diseases, e.g. rac...A61P 19/10 : for osteoporosisA61P 21/00 : Drugs for disorders of the ...A61P 21/04 : for myasthenia gravisA61P 25/00 : Drugs for disorders of the ...A61P 25/02 : for peripheral neuropathiesA61P 25/04 : Centrally acting analgesics...A61P 25/06 : Antimigraine agentsA61P 25/14 : for treating abnormal movem...A61P 25/16 : Anti-Parkinson drugsA61P 25/28 : for treating neurodegenerat...A61P 27/02 : Ophthalmic agentsA61P 29/00 : Non-central analgesic, anti...A61P 3/00 : Drugs for disorders of the ...A61P 3/04 : Anorexiants; Antiobesity ag...A61P 3/06 : AntihyperlipidemicsA61P 3/10 : for hyperglycaemia, e.g. an...A61P 31/04 : Antibacterial agentsA61P 31/12 : AntiviralsA61P 31/14 : for RNA virusesA61P 31/16 : for influenza or rhinovirusesA61P 31/20 : for DNA virusesA61P 35/00 : Antineoplastic agentsA61P 35/02 : specific for leukemiaA61P 35/04 : specific for metastasisA61P 37/00 : Drugs for immunological or ...A61P 37/06 : Immunosuppressants, e.g. dr...A61P 37/08 : Antiallergic agents antiast...A61P 43/00 : Drugs for specific purposes...A61P 5/00 : Drugs for disorders of the ...A61P 5/14 : of the thyroid hormones, e....A61P 7/00 : Drugs for disorders of the ...A61P 7/02 : Antithrombotic agents; Anti...A61P 9/00 : Drugs for disorders of the ...A61P 9/04 : Inotropic agents, i.e. stim...A61P 9/08 : Vasodilators for multiple i...A61P 9/10 : for treating ischaemic or a...C07D 213/74 : Amino or imino radicals sub...C07D 213/75 : Amino or imino radicals, ac...C07D 213/76 : to which a second hetero at...C07D 213/82 : in position 3C07D 215/12 : with substituted hydrocarbo...C07D 215/14 : Radicals substituted by oxy...C07D 215/20 : Oxygen atomsC07D 215/38 : Nitrogen atoms nitro radica...C07D 231/40 : Acylated on said nitrogen atomC07D 239/48 : Two nitrogen atomsC07D 239/49 : with an aralkyl radical, or...C07D 261/14 : Nitrogen atomsC07D 263/48 : Nitrogen atoms not forming ...C07D 285/135 : Nitrogen atomsC07D 285/16 : Thiadiazines; Hydrogenated ...C07D 401/12 : linked by a chain containin...C07D 405/12 : linked by a chain containin...C07D 409/12 : linked by a chain containin...C07D 417/04 : directly linked by a ring-m...C07D 417/12 : linked by a chain containin...C07D 471/04 : Ortho-condensed systems